| Literature DB >> 34767562 |
Chloe E Holden1,2, Sally Wheelwright1, Amélie Harle2, Richard Wagland1.
Abstract
BACKGROUND: Patients diagnosed with cancer face many challenges and need a good understanding of their diagnosis and proposed treatments to make informed decisions about their care. Health literacy plays an important role in this and low health literacy has been associated with poorer outcomes. The aims of this review are to identify which outcomes relate to health literacy in patients with cancer, and to combine this through a mixed studies approach with the patient experience as described through qualitative studies.Entities:
Mesh:
Year: 2021 PMID: 34767562 PMCID: PMC8589210 DOI: 10.1371/journal.pone.0259815
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1PRISMA diagram showing number of records reviewed at each step of the process.
From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71. For more information, visit: http://www.prisma-statement.org/.
Included papers reporting associations with health literacy (N = 58).
| Author, year, location | Participants | Cancer site(s), stage | Outcomes | Outcome measures | Association of health literacy with outcomes | Quality (MMAT score) |
|---|---|---|---|---|---|---|
| Brewer, 2009, USA [ | 133 | Breast, stage I-II | Estimating and interpreting recurrence risk | Measures developed for study | Lower HL: higher and more variable estimates of recurrence risk (p = 0.01), lower ease of understanding (p<0.001) | Higher (5) |
| Cartwright, 2017, USA [ | 752 | Multiple, all stages | Number of admissions | Rates from electronic medical records | Lower HL: greater number of inpatient hospital admissions (p = 0.009) and total number of days hospitalised (p = 0.023) | Higher (5) |
| Hahn, 2010, USA [ | 97 | Multiple, stage not reported | Health related quality of life | FACT-G | No significant difference in FACT-G scores | Higher (5) |
| Husson, 2015, The Netherlands [ | 1643 | Colorectal, stage not reported | Health related quality of life | Questions from European Prospective Investigation into Cancer PA Questionnaire | Lower HL: less likely to meet guidelines for physical activity (p<0.01), negative association with all HRQOL subscales (p<0.01), positive association with mental distress (p<0.01) | Higher (5) |
| Inglehart, 2016, USA [ | 372 | Head and neck, stage not reported | HPV related knowledge | Measures developed for study | Higher HL: greater HPV-related knowledge (p<0.01) | Higher (5) |
| Jiang, 2019, USA [ | 50 | Multiple, all stages | Chemotherapy adherence | Medication Event Monitoring System (MEMS®) | Higher HL: higher medication adherence (p = 0.03) | Higher (5) |
| Koay, 2013, Australia [ | 93 | Head and neck, lung, stage not reported | Distress | Distress thermometer | Lower HL: increased distress using HeLMS measure (p<0.05) but not using S-TOFHLA measure (p = 0.744) | Higher (5) |
| Nilsen, 2019, USA [ | 218 | Head and neck, stage 0-IV | Quality of life | University of Washington Quality of Life Scale (UWQOL) | Lower HL: lower clinically meaningful social QOL scores (p = 0.013) but not physical QOL scores (p = 0.13) | Higher (5) |
| Winton, 2016, USA [ | 336 | Breast, stage 0-IIIA | Type of initial operation for operable breast cancer | Medical record review | Higher HL: greater likelihood of breast reconstruction (non-significant in multivariate analysis, p = 0.06) | Higher (5) |
| Brewer, 2012, USA [ | 163 | Breast, stage I-II | Participant perception of how well results understood | Measures developed for study | Lower HL: lower perceived understanding of test results (p = 0.01) | Higher (4) |
| Busch, 2015, USA [ | 347 | Colorectal, stage I-IV | Receipt of adjuvant chemotherapy | Measures developed for study | Higher HL: increased odds of receiving chemotherapy (stage III/IV disease), no association with presentation with early-stage disease (all stages) nor death | Higher (4) |
| Chan, 2020, Malaysia [ | 345 | Multiple, stage I-IV | Preference for patient centred care | Patient Practitioner Orientation Scale (PPOS) | Higher HL: preference for patient centred care (p = 0.001) | Higher (4) |
| Chang, 2019, Taiwan [ | 120 | Multiple, stage not reported | Patient’s assessment of degree of shared decision making | 9-item Shared Decision Making Questionnaire (SDM-Q-9) | Higher HL: higher extent to which participants felt involved in shared decision making (p = 0.004) | Higher (4) |
| Chrischilles, 2019, USA [ | 835 | Breast, DCIS-III | Quality of life | Disabilities of Arm, Shoulder and Hand Questionnaire short form (QuickDASH) | Lower HL: greater disability (p = 0.0062), lower QOL (p = 0.0063) | Higher (4) |
| Clarke, 2021, Ireland [ | 395 | Head and neck, stage I-IV | Health related quality of life | FACT-G | Lower HL: lower self-management behaviours and functional wellbeing (p = 0.0220), lower disease specific HRQOL (p = 0.046), higher fear of recurrence (p = 0.040) | Higher (4) |
| Hendren, 2011, USA [ | 103 | Breast and colorectal, stage 0-IV | Patient navigation time | Total time spent with patient and addressing barriers summed and log-transformed to yield a normal distribution | Lower HL: increased navigation time (p = 0.02, non-significant in multivariate analysis) | Higher (4) |
| İlhan, 2020, Turkey [ | 207 | Multiple, stage not reported | Self-care management | Self-Care Management Process in Chronic Illness (SCMP-G). | Lower HL: lower self-care management (p<0.01) | Higher (4) |
| Lee, 2018, South Korea [ | 80 | Lung, stage II-IV (NSCLC), all stages (SCLC) | Quality of life | Self-care behaviours measured using previously developed unpublished tool | Lower HL: poorer general (p = 0.001) and disease related QOL (p<0.001, significant also in regression analysis), no significant association with self-care behaviours (p = 0.093) | Higher (4) |
| Lillie, 2007, USA [ | 163 | Breast, stage I-II | Preference for participation in decision making | Measures developed for study | Higher HL: greater number of correct answers (p<0.01), preference for more active participation in decision making (p = 0.03 in unadjusted analysis) | Higher (4) |
| Lim, 2019, Australia [ | 68 | Multiple, stage not reported | Cancer care coordination | Cancer Care Coordination Questionnaire (CCCQ) | Higher HL: better experience of cancer care coordination (p<0.001) | Higher (4) |
| Mahal, 2015, USA [ | 375 | Prostate, stage not reported–biochemical recurrence | Unproven use of early salvage androgen deprivation therapy (ADT) | Three validated questions developed as a part of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) index. | Higher HL: less likely to undergo salvage ADT (p = 0.016, non-significant in multivariate analysis p = 0.07) | Higher (4) |
| Matsuyama, 2011, USA [ | 138 | Multiple, stage II-IV | Information needs | Adapted Toronto Informational Needs Questionnaire (TINQ) | Lower HL: greater total (p<0.05), psychosocial and tangible information needs (both p<0.01 in bivariate analysis) | Higher (4) |
| McDougall, 2018, US [ | 277 | Colorectal, ‘localised or regional’ | Cancer treatment related financial hardship | Measures developed for study including questions from Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Supplement | Lower HL: greater financial hardship (p<0.05), no association with adherence to surveillance colonoscopy | Higher (4) |
| McDougall, 2019, USA [ | 301 | Colorectal, ‘localised or regional’ | Health related quality of life | Specific PROMIS Short Forms | Lower HL: higher pain interference, higher sleep disturbance and higher depression scores (all p<0.05 in multivariate analysis) | Higher (4) |
| Mohan, 2009, USA [ | 184 | Prostate, T1a-T2c | Perceived decrease in longevity with observation (PDLO) | PDLO and PILT calculated from self-assessment of life expectancy and Charlston Comorbidity Index to estimate baseline comorbidity adjusted life expectancy | PDLO and PILT not associated with HL | Higher (4) |
| Ousseine, 2020, France [ | 4045 | Multiple, stage not reported | Medico-social follow up | Questions developed for study | Lower HL: increased likelihood of follow up by GP and contact with social worker (in multivariable analysis), higher anxiety, depression, fatigue and sequelae following treatment (all p<0.001) | Higher (4) |
| Ozkaraman, 2019, Turkey [ | 111 | Multiple, stage I-IV | Quality of life | Self-Efficacy to Manage Chronic Disease (SEMCD) scale | Lower HL: poorer general QOL (p = 0.036) and increased symptom subscale score (p = <0.001), no significant association with self-efficacy | Higher (4) |
| Plummer, 2017, Australia [ | 36 | Breast, stage I-IV | Physical activity | Questions from Active Australia Survey. | Higher HL: greater physical activity (p<0.01) | Higher (4) |
| Polite, 2019, USA [ | 120 | Lung, gastric and pancreatic, stage not reported | Clinical trial attitudes, knowledge, and interest | 24 items from previously developed clinical trial questionnaire | Higher HL: increased willingness to take part in a clinical trial if offered (p = 0.049), no significant association with decision-making preferences | Higher (4) |
| Post, 2020, USA [ | 298 | Breast, stage 0-III | Patient engagement (knowing participation in change, patient activation) | Knowing Participation in Change Short Form (KPC-SF) | Higher HL: greater patient engagement (p≤0.001 in bivariate analysis only) | Higher (4) |
| Tagai, 2020, USA [ | 431 | Prostate, stage not reported | Self-efficacy for re-entry | Measures developed for study incorporating | Higher HL: greater self-efficacy for re-entry (p<0.001) and fewer practical concerns (p<0.05 in multivariable analysis) | Higher (4) |
| Xia, 2019, China [ | 4589 | Multiple, stage not reported | Quality of life | EORTC QLQ-C30 | Lower HL: poorer QOL (p<0.001 in logistic regression analysis) | Higher (4) |
| Anderson, 2021, USA [ | 183 | Multiple, stages I-III | Impact of cancer self-management on psychosocial functioning | Measures developed for study | Lower HL: higher psychosocial impact score (p<0.05) with indirect effect on general physical and mental health | Lower (3) |
| Bol, 2018, The Netherlands [ | 197 | Multiple, all stages | Recall of information | Questions developed for study based on the Netherlands Patient Information Recall Questionnaire (NPIRQ). | Higher HL: higher recall (p = 0.016 in multiple linear regression analysis) | Lower (3) |
| Douma, 2012, The Netherlands [ | 104 | Multiple, stage not reported | Information needs | Information Preferences of Radiotherapy Patients Questionnaire (IPRP) | Lower HL: greater decrease in need for information about treatment over time (p = 0.05) | Lower (3) |
| Gonderen Cakmak, 2020, Turkey [ | 100 | Multiple, stage not reported | Oral chemotherapy adherence | Oral Chemotherapy Adherence Scale (OCAS) | Higher HL: higher medication adherence (p = 0.000) | Lower (3) |
| Goodwin, 2018, Australia [ | 565 | Prostate, stage not reported | Quality of life | SF-36 | Higher HL: better mental health status (p<0.01), weaker associations with physical health status (p<0.01) | Lower (3) |
| Gunn, 2020, USA [ | 228 | Breast, all stages | Cancer related needs | Adapted Cancer Needs Distress Inventory (CaNDI) instrument | Lower HL: higher cancer-related needs at baseline (p<0.05 in multivariable analysis), lower self-efficacy at baseline (p<0.05) | Lower (3) |
| Gupta, 2020, India [ | 224 | Multiple, stage not reported | Adverse drug reactions | Identified by study investigator, graded and causality established | Lower HL: higher grade 3 and above adverse drug reactions (p<0.0001 in bivariate analysis) | Lower (3) |
| Halbach, 2016, Germany [ | 413 | Breast, stage 0-IV | Fear of progression | FoP-Q-SF | Lower HL: higher FoP (p<0.05) | Lower (3) |
| Heß, 2020, Germany [ | 449 | Breast, prostate, colorectal, stage not reported | Unexpressed needs | Measures developed for study | Lower HL: higher unexpressed needs (p<0.05) | Lower (3) |
| Heuser, 2019, Germany [ | 863 | Breast, stage 0-IV | Participation in multidisciplinary tumour conferences | Patient self-report of offer to participate and acceptance of this offer | Lower HL: less likely to participate in MTCs (p<0.05) | Lower (3) |
| Joyce, 2020, USA [ | 38 | Prostate, stage not reported | Treatment regret | Measured using previously developed items | Lower HL: higher treatment regret (p<0.05). | Lower (3) |
| Kappa, 2017, USA [ | 504 | Bladder, stage not reported | Use of post-operative discharge services | Medical records | Lower HL: greater use of discharge services (p = 0.016, non-significant in multivariable analysis) | Lower (3) |
| Kim, 2001, USA [ | 30 | Prostate, all stages | Prostate cancer knowledge | Measures developed for study | Higher HL: higher prostate cancer knowledge (p = 0.0001, bivariate analysis) | Lower (3) |
| Nakata, 2020, Germany [ | 927 | Breast, stage 0-IV | Need for psycho-oncological care | FoP-Q-SF | Lower HL: more likely to develop a need for psychological support (p = 0.003 in multiple regression analysis) | Lower (3) |
| Parker, 2020, USA [ | 46 | Breast, stage I-III | Chemotherapy knowledge | Leuven Questionnaire on Patient Knowledge of Chemotherapy (L-PaKC) | Higher HL: greater chemotherapy knowledge (p<0.05 in univariate analysis) | Lower (3) |
| Scarpato, 2016, USA [ | 368 | Bladder, pT0-4 | Post-operative complications | Medical records review | Lower HL: increased risk of developing minor complication (p<0.05 in multivariable regression analysis), no significant association with time to first ED visit or readmission | Lower (3) |
| Smith, 2020, Australia [ | 150 | Multiple, stage not reported | Knowledge and attitudes regarding clinical trials | Knowledge and Attitudinal Barrier Survey | Higher HL: better trials knowledge (p = 0.04 in multivariable regression analysis) | Lower (3) |
| Song, 2012, USA [ | 1581 | Prostate, T1-T2 | Health related quality of life | SF-12 | Lower HL: lower physical wellbeing (p<0.0001, non-significant in multivariable analysis) and poorer mental wellbeing (p = 0.0394 in adjusted model) | Lower (3) |
| Watson, 2020, USA [ | 100 | Gynae-cological, not reported | Medication adherence | Validated three item measure | Adherence not significantly associated with HL | Lower (3) |
| Yen, 2020, USA [ | 311 | Breast, stage not reported | Observed shared decision making | OPTION-5 | Observed shared decision-making not significantly associated with HL | Lower (3) |
| Eton, 2019, USA [ | 91 | Multiple, stage not reported | Health related quality of life | Global physical and mental health summary scores of PROMIS-10 | Lower HL: greater physical/mental exhaustion (p = 0.01 in linear regression analysis), and lower 6-month physical wellbeing (<0.05 in bivariate analysis) | Lower (2) |
| Halbach, 2016, Germany [ | 1060 | Breast, stage 0-IV | Unmet information needs | Modified version of Cancer Patients Information Needs (CaPIN) | Lower HL: higher unmet information needs (p<0.01) | Lower (2) |
| Janz, 2017, USA [ | 1295 | Breast, stage I-II | Doctor-patient communication regarding risk | Questions developed for study | Patient perception of whether doctor discussed recurrence risk not significantly associated with HL | Lower (2) |
| Rust, 2015, USA [ | 48 | Breast, stage not reported | Medication self-efficacy and adherence | Adherence to Refills and Medications Scale (ARMS) | Higher HL: higher medication adherence and self-efficacy for medication use (p = 0.044 and p = 0.027 in linear regression analysis) | Lower (2) |
| Turkoglu, 2019, Turkey [ | 126 | Bladder, non-muscle invasive | Compliance with cystoscopic follow up and treatment as per protocol | Unclear | Higher HL: higher treatment continuity rate (p = 0.008 in bivariate analysis) | Lower (2) |
| Wolpin, 2016, USA [ | 26 | Prostate, localised | Eye tracking patterns | Usability measured with Tobii T60 eye tracker and an observer form | Lower HL: more time spent on prognostic text and infographic | Lower (2) |
* Includes adults with cancer only. Multiple refers to more than three tumour sites. Abbreviations: EORTC QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30; FACT: Functional Assessment of Cancer Therapy (-B: Breast, -G: General, -HN: Head and neck; -L: Lung); FoP-Q-SF: Short version of the Fear of Progression Questionnaire; HADS: Hospital Anxiety and Depression Scale; HL: health literacy; HRQOL: Health related quality of life; NR: not reported; PETS: Patient Experience with Treatment and Self-Management framework; PROMIS-10: Patient-Reported Outcomes Measurement Information System-10; QOL: Quality of life; SF-12/36: 12/36-item Short Form Health Survey.
Association of outcomes to health literacy reported by included studies.
| Category | Association | Outcomes |
|---|---|---|
| Information processing | Lower health literacy: | Lower understanding [ |
| Poorer estimation of recurrence risk [ | ||
| Greater information needs and greater decrease in needs over time [ | ||
| More time spent on prognostic information and infographic (eye tracking) [ | ||
| Higher health literacy: | Higher recall [ | |
| Greater knowledge [ | ||
| Decision making | Higher health literacy: | Preference for more active participation [ |
| Higher perceived involvement [ | ||
| No association: | Preference for more active participation [ | |
| Observed shared decision making [ | ||
| Quality of life | Lower health literacy: | Poorer quality of life [ |
| No association: | Quality of life [ | |
| Treatment and health service use | Lower health literacy: | Increased number and length of hospital admissions [ |
| Increased likelihood of GP follow up for cancer [ | ||
| Increased use of post-operative discharge services [ | ||
| Increased likelihood of treatment complications [ | ||
| Higher health literacy: | Increased odds of receiving chemotherapy [ | |
| Increased likelihood of breast reconstruction [ | ||
| Lower likelihood of receiving unproven treatment [ | ||
| Greater treatment continuity [ | ||
| No association: | Hospital admissions and emergency department visits [ | |
| Adherence to recommended follow up [ | ||
| Medication adherence | Higher health literacy: | Higher medication adherence [ |
| No association: | Medication adherence [ | |
| Care coordination | Lower health literacy: | Poorer experience of care coordination [ |
| Greater requirement for patient navigation assistance [ | ||
| Lower likelihood of patient participation in multidisciplinary tumour conferences [ | ||
| Other | Lower health literacy: | Lower levels of physical activity [ |
| Higher cancer related and unexpressed needs [ | ||
| Greater need for psychological support [ | ||
| Increased financial hardship [ | ||
| Increased fear of progression or recurrence [ | ||
| Greater treatment regret [ | ||
| Lower self-care management [ | ||
| Greater distress [ | ||
| Increased upper extremity disability after breast cancer [ | ||
| Higher health literacy: | Greater self-efficacy [ | |
| Preference for patient centred care [ | ||
| Greater patient engagement [ | ||
| Fewer practical concerns [ | ||
| Increased willingness to participate in a clinical trial if offered [ | ||
| No association: | Self-efficacy [ | |
| Mortality [ | ||
| Distress [ | ||
| Perception of doctors’ communication of recurrence risk [ | ||
| Perceived changes to longevity with treatment or observation [ | ||
| Presentation with early stage disease [ | ||
| Self-care behaviours [ |
Qualitative studies exploring the role of health literacy in patients to access, understand, appraise and use information and services to make decisions about health.
| First author, year, location | Aim/objectives | Study design | Sample characteristics (number, tumour sites, age range, sex) | Key themes and findings | MMAT score |
|---|---|---|---|---|---|
| Burks, 2020, USA [ | To assess the perceptions of risks, benefits, and the informed consent process for patients already enrolled in a phase 2 clinical trial using intraoperative radiation therapy (IORT) with a nested study exploring how the perceptions of risks and benefits of clinical trial enrolment differed based on varying levels of health literacy | Structured interviews with convenience sample of participants already recruited to phase 2 parent study. Health literacy assessed using screening questions. | 20 participants, early stage breast cancer, 45–90 years, 100% female | Weight of risks and benefits | 5 |
| Cohen, 2013, USA [ | To describe the meaning of patients’ experiences with hematopoietic stem cell transplantation (HSCT), with a focus on health literacy. | Interviews using open ended questions conducted at five time points from pre-transplantation to 100 days post. | 60 participants, haematological malignancies, undergoing stem cell transplant, 22–71 years, 50% female | They did not tell me | 5 |
| Kayser, 2015, Denmark [ | To explore whether the scores of and responses to a Health Literacy Questionnaire (HLQ) can be used to identify individuals in need of information and support, to reveal differences in perception and understanding in health related situations within couples and to explore whether the health literacy domains constituting the HLQ emerged as themes important to the men and their spouses. | Mixed methods approach. Patients and spouses interviewed separately using HLQ as framework for questioning. | 8 patient participants, early stage prostate cancer, 55–70 years, 100% male | Involvement of their spouses and people around them | 3 |
| Martinez-Donate, 2013, USA [ | To identify the health literacy barriers and patient navigation needs of rural cancer patients in Wisconsin using the Chronic Care Model as a guiding and integrative framework. | Mixed methods approach. Face to face semi structured interviews with patients from five centres. Health literacy assessment performed. Closed ended question survey later completed by telephone. Focus groups and surveys with clinical staff. | 53 participants, multiple tumour sites (breast, lung, colorectal and prostate), 39–86 years, 63% female | Community Characteristics | 2 |
| Oliffe, 2011, Canada [ | To describe how men who attend prostate cancer support groups (PCSGs) engage with health literacy and consumerism. | Part of larger ethnographic study. Participant observation at support group meetings and fundraising events as well as individual interviews. | 54 participants, prostate cancer, 53–87 years, 100% male | Numbers and measures as the foundation of prostate cancer literacy | 5 |
| Rust, 2011, USA [ | To explore the issues of health literacy and medication adherence among underserved breast cancer survivors | Two focus groups containing 12 participants each. | 24 participants, breast cancer, age range not reported, 100% female | Inequality of access to health information | 5 |
| Treloar, 2013, Australia [ | To understand and integrate the perspectives of Aboriginal people, their carers and health workers regarding the health literacy required for engaging with cancer screening, diagnosis, care and treatment. | Semi-structured in-depth interviews with patients, carers and healthcare workers | 22 patient participants, tumour sites and age range not reported, 73% female | Recognising susceptibility to cancer | 5 |
| Zanchetta, 2007, Canada [ | To describe, analyse, and understand the participants’ ways of understanding and dealing with PC-related information as demonstrated by their informational strategies. | Open-ended, semi-structured interviews, participants’ personal journals, personal documents, genograms and ecomaps, interviewer’s observational notes, and observation of nonverbal cues during the interviews. | 15 participants, localised prostate cancer, 61–83 years, 100% male | Social and informational networks | 4 |
Meta-themes and the contributory themes extracted from original papers.
| Meta-themes | Themes from original papers |
|---|---|
| Situational influences | Relying on others [ |
| • Networks | Involvement of their spouses and the people around them [ |
| Group information processing [ | |
| Recognising opportunities to learn from each other [ | |
| Social and informational networks [ | |
| Their use of the internet for information retrieval [ | |
| Pragmatic decision making [ | |
| Situational influences | Overcoming professional medical language [ |
| • System | Self-management support [ |
| Delivery system design [ | |
| Support from and interaction with healthcare professionals [ | |
| Opportunities for practical services and programmes for health literacy in relation to cancer [ | |
| Inequality of access to health information [ | |
| They did not tell me [ | |
| Decision support [ | |
| Confidence in provider recommendation [ | |
| Personal influences | Recognising susceptibility to cancer [ |
| Community characteristics [ | |
| Spiritual and emotional influences [ | |
| Literacy levels [ | |
| Silence among men [ | |
| Information processing | Numbers and measures as the foundation of prostate cancer literacy [ |
| Deductive and hypothetical reasoning [ | |
| Weight of risks and benefits [ | |
| Consequences | Shopping around [ |
| Decision dilemmas [ | |
| Fears of dying [ | |
| Tough symptoms and side-effects [ | |
| Medication usage and adherence [ | |
| Acquisition of medication information [ |
Fig 2Concept map demonstrating links between findings from quantitative and qualitative data as ‘Processes’, ‘Outcomes’ and ‘Influences’ of health literacy.